Results
26,614 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 32 | Robbins Edward Hutchinson Jr.EVP, General Counsel |  TLSTELOS CORPOpen-market sale | SELL | $259K 64.5K sh | Mar 19, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 32 | Robbins Edward Hutchinson Jr.EVP, General Counsel | TLSTELOS CORP Open-market sale | SELL | $259K 64.5K sh | Mar 19, 2026 |
| 32 | Lin Elizabeth YeuChief Medical Officer |  TARSTarsus Pharmaceuticals, Inc.Open-market sale | SELL | $26K 379 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 32 | Valentine CurtisChief Financial Officer |  SFMSprouts Farmers Market, Inc.Open-market sale | SELL | $15K 183 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 32 | Zalatoris TimmiChief Human Resources Officer | SFMSprouts Farmers Market, Inc. Open-market sale | SELL | $49K 585 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 32 | Hoitt JasonChief Patient Officer |  STOKStoke Therapeutics, Inc.Open-market sale | SELL | $4,419 139 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 30 | Lam DennisDirector |  HFFGHF Foods Group Inc.Open-market purchase | BUY | $176 100 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 29 | Agrawal NitinChief Financial Officer |  CRWVCoreWeave, Inc.Open-market sale · 10b5-1 plan | SELL | $711K 8,666 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 29 | Allan JonathanGENERAL COUNSEL & CORP SEC | STOKStoke Therapeutics, Inc. Open-market sale | SELL | $2,365 72 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 29 | Allan JonathanGENERAL COUNSEL & CORP SEC | STOKStoke Therapeutics, Inc. Open-market sale | SELL | $11K 334 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 29 |  August PflugerRSelf |  WBDWarner Bros. Discovery, Inc. - Series A Common StockSale | SELL | $1,001 – $15K | Mar 19, 2026 traded Feb 10, 2026 |
| 28 | Liegel Matthew AChief Accounting Officer |  TGTTARGET CORPOpen-market sale | SELL | $241K 2,053 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 28 | Reed Marcy L.Director |  CLHCLEAN HARBORS INCOpen-market sale | SELL | $241K 836 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 28 | von Heynitz HaraldDirector |  FLNCFluence Energy, Inc.Open-market sale | SELL | $165K 10.0K sh | Mar 19, 2026 traded Mar 18, 2026 |
| 28 | Wills Phillip R. IIIDirector |  FVCBFVCBankcorp, Inc.Open-market sale | SELL | $170K 11.5K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 23 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner |  DSPViant Technology Inc.Open-market sale · 10b5-1 plan | SELL | $60K 5,000 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 23 | Agrawal NitinChief Financial Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $25K 300 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 23 | Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $60K 5,000 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 23 | Capital V LLC10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $180K 15.0K sh | Mar 19, 2026 traded Mar 18, 2026 |
| 23 | Capital V LLC10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $100K 8,760 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 23 | Geller AdamChief Product Officer |  ZSZscaler, Inc.Open-market sale · 10b5-1 plan | SELL | $233K 1,485 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 22 | Geller AdamChief Product Officer | ZSZscaler, Inc. Open-market sale · 10b5-1 plan | SELL | $321K 2,094 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 22 | Woolsey Staci MChief Financial Officer |  GVAGRANITE CONSTRUCTION INCOpen-market sale · 10b5-1 plan | SELL | $183K 1,523 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 21 | Larkin Kyle TDirector, President & CEO | GVAGRANITE CONSTRUCTION INC Open-market sale · 10b5-1 plan | SELL | $877K 7,314 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 21 | Tamari ShaharDirector, COO |  GLBEGlobal-E Online Ltd.Open-market sale · 10b5-1 plan | SELL | $563K 16.7K sh | Mar 19, 2026 traded Mar 18, 2026 |
| 20 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $33K 2,920 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 20 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $86K 2,587 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 20 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $191K 6,100 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 20 | Beer James ADirector | ZSZscaler, Inc. Open-market sale · 10b5-1 plan | SELL | $27K 177 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 20 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $117K 3,577 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 20 | Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $33K 2,920 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 19 | Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $59K 5,000 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 19 | Capital V LLC10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $177K 15.0K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 19 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $59K 5,000 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 18 | Kelly Patrick ArthurCo-President and COO |  CIFRCipher Digital Inc.Open-market sale · 10b5-1 plan | SELL | $533K 35.6K sh | Mar 19, 2026 traded Mar 16, 2026 |
| 16 | Baroni DarioPresident, IDL |  MCDMCDONALDS CORPOpen-market sale · 10b5-1 plan | SELL | $194K 600 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 15 | Peterson JustinChief Technology Officer |  TWTradeweb Markets Inc.Open-market sale · 10b5-1 plan | SELL | $401K 3,212 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 15 | Verjus Nathalie Claude OdileCompany Secretary |  LAESSEALSQ CorpOpen-market sale · 10b5-1 plan | SELL | $15K 5,000 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 13 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $44K 1,461 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 13 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $3,384 103 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 13 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $15K 483 sh | Mar 19, 2026 traded Mar 18, 2026 |